MIPI - Mantle Cell Lymphoma International Prognostic Index
Stratifies prognosis in advanced-stage mantle cell lymphoma using a selected MIPI variant (Clinical, Biologic MIPIb with Ki-67, or Simplified point table) from age, ECOG, LDH/ULN, and WBC, into low/intermediate/high risk groups.